Deutsche Bank’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Deutsche Bank’s Portfolio SNNA Stock Details SNNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,854	Closed	-$3K	–	5501
2019 Q2	$3K	Sell	3,854 -15,395	-80%	-$24.1K	﹤0.01%	5163
2019 Q1	$44K	Sell	19,249 -85,469	-82%	-$232K	﹤0.01%	4598
2018 Q4	$241K	Buy	104,718 +67,052	+178%	+$591K	﹤0.01%	3784
2018 Q3	$558K	Buy	37,666 +2,230	+6%	+$35.4K	﹤0.01%	3720
2018 Q2	$538K	Buy	35,436 +13,452	+61%	+$228K	﹤0.01%	3812
2018 Q1	$412K	Buy	21,984 +10,646	+94%	+$186K	﹤0.01%	3816
2017 Q4	$205K	Buy	11,338 +6,609	+140%	+$140K	﹤0.01%	4022
2017 Q3	$104K	Buy	+4,729	New	+$104K	﹤0.01%	4156

Other funds holding SNNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GSWM

Golden State Wealth Management Santa Ana, California $1.1B AUM 27.5% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Deutsche Bank's SNNA Position: Q3 2019 in Review

Deutsche Bank sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q3 2019, closing a stake of 3,854 shares — an estimated $3K sold.

Deutsche Bank first reported a position in SNNA in Q3 2017 and held it in 8 quarters. The position peaked at $558K in Q3 2018. 23 funds tracked by Wall St. Rank hold SNNA as of Q3 2019.

Deutsche Bank reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Deutsche Bank sold 3,854 Sienna Biopharmaceuticals, Inc. shares in Q3 2019, an estimated $3K.
Deutsche Bank first reported a position in Sienna Biopharmaceuticals, Inc. in Q3 2017 and held it in 8 quarters.
Deutsche Bank's Sienna Biopharmaceuticals, Inc. position peaked at $558K in Q3 2018.
23 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q3 2019.

Based on Deutsche Bank's 13F filing for Q3 2019, filed 14 Nov 2019.